Our Technology
At Medaigraph, we are revolutionizing the production of biomedical-grade graphene and graphene oxides through our proprietary AI-optimized Liquid Phase Exfoliation (LPE) technology. Our advanced approach ensures the highest purity, consistency, and scalability, making graphene-based materials ideal for next-generation drug delivery, biosensing, and regenerative medicine applications.
Our Core Technologies:
AI-Driven Precision in Graphene Production
Traditional graphene exfoliation methods often result in inconsistent flake sizes, impurities, and low yields. Our AI-optimized LPE technology overcomes these challenges by integrating real-time process monitoring, machine learning-driven optimization, and molecular-level control.
Breakthroughs in Drug Delivery Applications
Our graphene and graphene oxide (GO) nanostructures enable targeted drug delivery with controlled release, enhanced biocompatibility through AI-driven purification, high drug-loading capacity, and stimuli-responsive release triggered by pH, temperature, or external factors, optimizing therapeutic efficacy.
Research & Development (R&D)
Our dedicated R&D team collaborates with global research institutions and industry leaders to push the boundaries of battery technology. Through continuous innovation, we address emerging market challenges and pioneer solutions that set new industry standards.
